Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) — Stock Score Summary

Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) has a MoatMap StockRank of 10/100 based on Quality (32/100), Value (35/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. Sichuan Biokin Pharmaceutical is a clinical-stage oncology biotech. While its bispecific antibody-drug conjugate (ADC) pipeline has high potential, it is a pre-revenue, highly speculative R&D story that does not fit our criteria for a high-ROIC, cash-generative compounder.

Sichuan Biokin Pharmaceutical Co., Ltd. develops innovative oncology therapeutics, with a strong focus on multi-specific antibodies and antibody-drug conjugates (ADCs). The company possesses a highly advanced, proprietary bispecific ADC platform, leading to high-value global licensing deals. It is a high-potential biotechnology innovator transitioning from traditional pharmaceuticals to cutting-edge global oncology therapeutics.

Key Financial Metrics

Price$32.21
Market Cap$14.6B
Price/Book15.51
Return on Equity-28.8%
Return on Invested Capital-6.7%
Debt/Equity76.52
Gross Margin89.5%
Operating Margin-805.4%
Revenue Growth40.3%
Free Cash Flow$-69M

Sichuan Biokin Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sichuan Biokin Pharmaceutical Co.,Ltd.’s (688506.SS) StockRank?
MoatMap’s StockRank for Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) is 10/100, with a Strong Sell signal. It is a composite of Quality (32), Value (35), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sichuan Biokin Pharmaceutical Co.,Ltd. have an economic moat?
Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sichuan Biokin Pharmaceutical Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) is Strong Sell, based on a StockRank of 10/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sichuan Biokin Pharmaceutical Co.,Ltd. in?
Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks688506.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock